NEW YORK (GenomeWeb News) — The US Department of Defense has awarded Applied Biosystems a $24.5 million contract to develop a prototype system that can identify infectious diseases for epidemiological and biosecurity purposes.
ABI said the company has already presented “key components” of the prototype to the United States Air Force, which will validate it.
According to ABI, the system will use a multiplex assay to identify emerging pathogens. Early prototypes can already ID 10 pathogens simultaneously on a test array, the firm said.
The company added that, once completed, the system could be used in other applications in biosecurity, forensics, animal testing, and food quality testing --- applied markets that ABI hopes will fatten its top line over the next two years.